title: Tumor lysis syndrome following chlorambucil therapy for chronic lymphocytic leukemia: case report and review of the literature.
authors.affiliation: Division of Hematology/Medical Oncology, Department of Internal Medicine, East Tennessee State University, Johnson City, USA. semaankosseifi@yahoo.com
authors.forename: Semaan G
authors.initials: SG
authors.lastname: Kosseifi
authors.forename: Bavna
authors.initials: B
authors.lastname: Vyas
authors.forename: Harsha
authors.initials: H
authors.lastname: Vyas
authors.forename: Guha
authors.initials: G
authors.lastname: Krishnaswamy
authors.forename: Steven
authors.initials: S
authors.lastname: Smith
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D002699:Chlorambucil / Q000009:adverse effects*; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D008297:Male; D012307:Risk Factors; D015275:Tumor Lysis Syndrome / Q000209:etiology*; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives
chemical_list: D000970:Antineoplastic Agents; D018906:Antineoplastic Agents, Alkylating; D005938:Glucocorticoids; D002699:Chlorambucil; D014740:Vidarabine; C024352:fludarabine